Back to Search

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

  • Protocol Number: 202106129
  • Principal Investigator: Colditz, Graham
  • Cancer Types: Gastrointestinal

Learn more about this study at: clinicaltrials.gov

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants’ health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.

Protocol Interventions

Other: Return of Genetic Results: Biomarker information from cancer cells, Other: Return of Genetic Results: Inherited mutations related to cancer, Other: Return of Genetic Results: Inherited mutations related to other medical issues